Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit

Opyl featured in the machine learning-based drug discovery theme in an article on biotech segments VCs are investing and ASX companies operating in the segments.

“There has been rapid advances in machine learning and AI that promise to accelerate drug discovery.”

“Machine learning allows drug development through computer-modeled simulations that predict molecular behaviour.”

“The technology is being increasingly used for phenotypic screening and genetic-profiling that can identify new genetic variants.”

Read the full article on Stockhead website: https://stockhead.com.au/health/check-up-these-biotech-themes-got-billions-in-vc-funding-these-asx-stocks-could-benefit/